Invention Grant
- Patent Title: Immunogenic antigens from Aspergillus fumigatus
-
Application No.: US14824957Application Date: 2015-08-12
-
Publication No.: US09770495B2Publication Date: 2017-09-26
- Inventor: Alexander Scheffold , Petra Bacher , Olaf Kniemeyer , Janka Teutschbein , Axel Brakhage
- Applicant: Miltenyi Biotec GmbH , Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute (HKI)
- Applicant Address: DE Bergisch-Gladbach DE Jena
- Assignee: MILTENYI BIOTEC GMBH,Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute
- Current Assignee: MILTENYI BIOTEC GMBH,Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute
- Current Assignee Address: DE Bergisch-Gladbach DE Jena
- Agency: Morrison & Foerster LLP
- Priority: EP14181113 20140815
- Main IPC: A61K39/00
- IPC: A61K39/00 ; G01N33/50

Abstract:
The present invention provides the in-vitro use of at least one in-vivo-target antigen of Aspergillus fumigatus for selective activation, detection and/or analysis of Aspergillus fumigatus specific CD4+ T cells in a sample comprising cells, wherein said at least one in-vivo-target antigen reveals an immune reactivity characterized by i) the in vivo existence of antigen-specific T cells comprising more than 60% memory T cells and ii) said antigen-specific T cells further comprise T cells able to produce IFN-gamma upon stimulation at a frequency between 15% and 80% and/or IL17 upon stimulation at a frequency between 5% and 30%. Said at least one in-vivo-target antigen may be selected from the group consisting of antigens Scw4, Pst1, Shm2, GliT and TpiA or fragments thereof. Also provided are a method, a composition, and a kit thereof.
Public/Granted literature
- US20160047809A1 IMMUNOGENIC ANTIGENS FROM ASPERGILLUS FUMIGATUS Public/Granted day:2016-02-18
Information query